Connect Qualitative Interviews

February 26, 2026 updated by: Baylor Research Institute

Maximizing Communication of Evidence to Inform the Public to Engage in Observational Research for Cancer Prevention

Goal of the study is to conduct Qualitative Interviews to identify and address barriers to study enrollment from various communities in order to increase the effectiveness and reach of our research to all people in the USA.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

A major aim of study is to increase the impact of observational research studies and to improve information disseminated to the broader U.S. public by maximizing trust with researchers and providing clear evidence that can assist in making informed healthcare decisions, improving healthcare delivery, and improving outcomes. The study aims to garner public and patient input to inform best practices for engaging with patients, caregivers, and the broader healthcare community; identifying their research priorities; and reducing risk factors that lead to many non-communicable diseases including cancer.

Study Type

Observational

Enrollment (Actual)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Dallas, Texas, United States, 75204
        • Baylor Scott and White Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

BSW patients between the age of 30-70 with no history of cancer*

Description

Inclusion Criteria:

  • Patients of Baylor Scott and White Health
  • Age between 30 and 70 years old at study invitation

Exclusion Criteria:

  • Individuals with a history of invasive cancer (other than non-melanoma skin cancer)
  • Individuals with known cognitive impairment documented in their medical record

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Connect Participants
Participants enrolled in the Connect for Cancer Prevention Study at BSWH
Other: Qualitative Interview
Qualitative Interview with study participants
Other: Qualitative Survey
This is an exploratory qualitative study consisting of one semi-structured interview
Other: Survey using a questionnaire.
This is an exploratory qualitative study consisting of one semi-structured interview

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative Interviews
Time Frame: From enrollment to the end of the study at 6 months
Conduct Qualitative with the Connect Study participants to identify and address barriers to enrollment from various communities in order to increase the effectiveness and reach of our research to all people in the USA.
From enrollment to the end of the study at 6 months
Qualitative Interviews
Time Frame: From enrollment to the end of interviews at 6 months
Conduct qualitative interviews to understand barriers to enrollment from various communities in order to increase the effectiveness and reach of our research to all people in the USA.
From enrollment to the end of interviews at 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Baylor Research Institute

Collaborators

National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Katherine Sanchez, PhD, Baylor Scott and White Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 12, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

February 26, 2026

First Submitted That Met QC Criteria

February 26, 2026

First Posted (Actual)

March 2, 2026

Study Record Updates

Last Update Posted (Actual)

March 2, 2026

Last Update Submitted That Met QC Criteria

February 26, 2026

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 025-308

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

Two years

IPD Sharing Access Criteria

Contact Principal Investigators

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Qualitative Research

Clinical Trials on Qualitative Interview

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe